6 Ways to Personalize Your Patient’s Asthma Treatment Plan
Asthma management is increasingly becoming more personalized. Here are 6 ways you can help personalize treatment for your patients with asthma that is severe or difficult to control.
In infancy, you can see feeding problems, and as the child progresses to adulthood, you will see them complain about vomiting, abdominal pain, difficulty swallowing, food impaction, and all of this may cause them to avoid eating certain foods, eat very slowly, or avoid social situations where food is involved.
Bronchiectasis unrelated to cystic fibrosis is the third most common chronic pulmonary disorder after asthma and chronic obstructive pulmonary disease.1 Bronchiectasis has multiple causes and is characterized by recurrent and often chronic productive cough, lower airway infection and inflammation, and irreversible bronchial dilatation.2 Irrespective of the...
Both clonal hematopoiesis of indeterminate potential (CHIP) and cancer are more common with age. When they coexist in the same patient, CHIP cells may migrate to the tumor and have an adverse effect on overall survival.
Oriol Pich, Elsa Bernard, Maria Zagorulya, Andrew Rowan, Constandina Pospori, Ramy Slama, Hector Huerga Encabo, Jennifer O’Sullivan, Despoina Papazoglou, Panayiotis Anastasiou, Chrysante S. Iliakis, Sally-Ann Clark, Krijn K. Dijkstra, Vittorio Barbè, Chris Bailey, Aaron J. Stonestrom, Katey S.S. Enfield, Mary Green, Charlotte K. Brierley, Alastair Magness, David R. Pearce, Robert E. Hynds, Rija Zaidi, Jayant K. Rane, Ángel F. Álvarez-Prado, Kerstin Thol, Rachel Scott, Supreet Kaur Bola, Elena Hoxha, Steve K. Harris, Karl S. Peggs, Sergio A. Quezada, Allan Hackshaw, Simone Zaccaria, Johanna A. Joyce, Ilaria Malanchi, Michael F. Berger, Mariam Jamal-Hanjani, Andreas Wack, Julian Downward, William Grey, Cristina Lo Celso, Eva Grönroos, Charles M. Rudin, Adam J. Mead, Dominique Bonnet, Elli Papaemmanuil, Charles Swanton
The author describes the scientific foundations of a phase 3 study of brensocatib for the treatment of bronchiectasis.
Adam T. Hill
RMEI LIGHTNING TALKS
View Details
4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far
RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.
Allergy & Immunology
2021
View Details
Effectiveness of 5-year IBD Provider Online Educational Intervention Program
There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.
Latest Allergy & Immunology Articles
